Compare NSPR & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | UG |
|---|---|---|
| Founded | 2005 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 30.8M |
| IPO Year | 2009 | 1995 |
| Metric | NSPR | UG |
|---|---|---|
| Price | $0.72 | $7.29 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 116.6K | 4.5K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 7.10% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $2,310,000.00 | ★ $10,545,468.00 |
| Revenue This Year | $57.98 | N/A |
| Revenue Next Year | $95.41 | N/A |
| P/E Ratio | ★ N/A | $35.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.63 | $5.58 |
| 52 Week High | $2.93 | $9.88 |
| Indicator | NSPR | UG |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 59.08 |
| Support Level | $0.69 | $6.85 |
| Resistance Level | $1.04 | $7.42 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 68.23 | 74.47 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.